Cover Image

Effects of ranibizumab (Lucentis®) and bevacizumab (Avastin®) on human corneal endothelial cells

Show other versions (1)

Ingrowth of newly formed blood and lymph vessels (angiogenesis) from the limbus region into the cornea can be treated successfully by subconjunctival application of antiangiogenic agents. Currently, there are several angiogenesis inhibitors from various manufacturers available, such as vascular endo...

Full description

Saved in:
Bibliographic Details
Main Authors: Merz, Patrick (Author) , Ballikaya, Seda (Author) , Auffarth, Gerd U. (Author) , Schmack, Ingo (Author)
Format: Article (Journal)
Language:English
Published: 11 December 2018
In: BMC ophthalmology
Year: 2018, Volume: 18
ISSN:1471-2415
DOI:10.1186/s12886-018-0978-9
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12886-018-0978-9
Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12886-018-0978-9
Get full text
Author Notes:Patrick R. Merz, Nina Röckel, Seda Ballikaya, Gerd U. Auffarth and Ingo Schmack
Search Result 1
Cover Image

Effects of ranibizumab (Lucentis®) and bevacizumab (Avastin®) on human corneal endothelial cells by Merz, Patrick (Author) , Röckel, Nina (Author) , Ballikaya, Seda (Author) , Auffarth, Gerd U. (Author) , Schmack, Ingo (Author) ,

BioMed Central 01 Feb. 2019 Universitätsbibliothek Heidelberg 01 Feb. 2019

Get full text
Article (Journal) Online Resource

Saved in:
Show all versions (2)

Similar Items